University Of Notre Dame Du Lac Sage Therapeutics, Inc. Transaction History

University Of Notre Dame Du Lac

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $2.58 Million - $2.99 Million	-16,334 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $414,937 - $760,154	-4,645 Reduced 22.14%	16,334 $2.6 Million
Q4 2018 Feb 13, 2019	BUY	$81.94 - $139.71 $202,555 - $345,363	2,472 Added 13.36%	20,979 $2.01 Million
Q3 2018 Nov 13, 2018	BUY	$138.11 - $169.04 $370,687 - $453,703	2,684 Added 16.96%	18,507 $2.61 Million
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $2.31 Million - $2.89 Million	-16,455 Reduced 50.98%	15,823 $2.48 Million
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $4.91 Million - $6.21 Million	32,278 New	32,278 $5.2 Million
Q4 2017 Feb 13, 2018	SELL	$60.72 - $167.34 $1.83 Million - $5.04 Million	-30,144 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$61.4 - $88.52 $1.85 Million - $2.67 Million	30,144	30,144 $1.88 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.